Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Tailwind Capital Closes Third Fund With $1.8 Billion

Posted in Healthcare Services Investing

Tailwind Capital has announced it has closed its third fund, Tailwind Capital Partners III, at $1.8 billion of commitments.

Tailwind indicated the funding will be used to continue the firm’s existing investment strategy.

Based in New York, Tailwind is a middle-market private equity firm focused on growth-oriented investments within healthcare and a few other sectors. The firm primarily targets companies with enterprise values up to $250 million. Current healthcare companies in its portfolio include Abode Healthcare (which was an investment from the new fund), Cumberland Consulting Group, Edenbridge Pharmaceuticals and National HME.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.